Hepatitis B Acceptability and Vaccination Incentive Trial

Not Applicable

Completed

• Conditions: Hepatitis B; Public Health - Other public health; Inflammatory and Immune System - Other inflammatory or immune system disorders

• Registration Number: ACTRN12608000436370
• Lead Sponsor: The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-08-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1) Aged 16 years and above; 2) Injected drugs at least once in the preceding 6 months; 3) No previous hepatitis B infection, and a maximum of one previous dose of hepatitis B vaccination, or unknown infection and vaccination status, based on self-report and, where available medical records; 4) ability to provide informed consent, to be randomised and attend vaccinations over a period of 3 weeks and attend follow up at 12 weeks post randomisation.

Exclusion Criteria

Evidence of natural or vaccine induced immunity; 2) Previous exposure or two+ vaccinations (as identified by self report), where HBV surface antibody =10 mIU/ml; 3) Serious mental or physical illness or disability likely to impact on capacity to complete the study procedures; 4) Insufficient English language skills that will impair ability to give informed consent or provide reliable responses to study interviews/questionnaires; 5) Human Immunodeficiency Virus (HIV) infection; 6) Refusal to be vaccinated against hepatitis B.

Study & Design

• Study Type: Interventional
• Study Design: Not specified